Cochrane risk-of-bias tool for randomized trials (RoB 2) for <strong>Omega-3 fatty acid supplementation for depression in children and adolescents</strong>

Abstract

This is the detailed risk of bias assessment data (with consensus responses to the signalling questions) for each outcome from the Excel ROB2 spreadsheet</p